Stoke Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
28.04.23
/
50%
€8.85
Target price
28.04.24
€21.78
Performance (%)
28.81%
End price
29.04.24
€11.40
Summary
This prediction ended on 29.04.24 with a price of €11.40. The BUY prediction by Canaccord_Genuity_Gr finished with a performance of 28.81%. Canaccord_Genuity_Gr has a follow-up prediction for Stoke Therapeutics Inc where he still thinks Stoke Therapeutics Inc is a Buy. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Stoke Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
In the thread Trading Stoke Therapeutics Inc
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by Canaccord_Genuity_Gr for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€28.40
20.03.26
20.03.26
€51.88
20.03.27
20.03.27
-8.98%
17.07.26
17.07.26
